<p>Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum]</p>

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum] Hua J, Qian W, Wu X, et al. Onco Targets Ther. 2020;13:2311–2317. The authors of this paper have advised that the author and affiliation list on page 2311 is incorrect. The correct author and affiliation list is as follows:Jingsheng Hua1,2,*Weiqing Qian3,*Xiaoxia Wu1,*Lili Zhou1Lei Yu4Suning Chen1Jian Zhang1Huiying Qiu11Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, Jiangsu, People’s Republic of China; 2Department of Hematology, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang, People’s Republic of China; 3Suzhou Vocational Health College, Suzhou, Jiangsu, People’s Republic ofChina; 4College of Chemistry andMolecular Engineering, East China Normal University, Shanghai, People’s Republic of China*These authors contributed equally to this workThe authors have also advised that the correspondence section on page 2311 is incorrect. The correspondence section shouldread as follows:Correspondence: Huiying Qiu; Jian ZhangTel +8613912792913Fax +8651267781850Email qiuhuiying8303@suda.edu.cn; crystalzj06@163.comRead the original article